FY2024 EPS Estimates for Ascendis Pharma A/S (NASDAQ:ASND) Decreased by Cantor Fitzgerald
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) – Investment analysts at Cantor Fitzgerald cut their FY2024 earnings per share (EPS) estimates for Ascendis Pharma A/S in a research note issued on Tuesday, October 1st. Cantor Fitzgerald analyst L. Watsek now expects that the biotechnology company will earn ($6.80) per share for the year, down from […]
More Stories
You Can’t Skip These Roblox Competitors
Roblox has introduced millions of joystick junkies and developers to the world for creating amazing games and igniting their creative...
11 Top Canadian Actors Dominating Hollywood
Jim Carrey and Nina Dobrev are among the top Canadian actors dominating Hollywood. Curious what this blog is about? Here,...
Top Female Superheroes that have Made History with Superpowers
Are you also one who thinks that a superhero means a powerful male or something like that? But superheroes don’t...
Bose Lifestyle Ultra Speaker Review 2026: Specification and Limitations
Looking for the best speaker in the market to upgrade your home? The Bose speaker is getting positive feedback from...
Goat Movie is Streaming on Netflix Now!
I love watching animated comedy films, but sometimes I’m unable to because they’re only available in selected regions. The Goat...
Best Music Streaming Apps in North America with Free Trials
I have spent many nights searching for the best music streaming apps. Are you also searching for the best music...